Structure-cytotoxicity relationships for dietary flavonoids

In Vitro and Molecular Toxicology: Journal of Basic and Applied Research

Volumn 11, Issue 2, 1998, Pages 193-206

  Breinholt, Vibeke ^a   Dragsted, Lars Ove ^a  

^a DANISH VETERINARY AND FOOD ADMINISTRATION   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; ERIODICTYOL; FISETIN; FLAVONOID; LUTEOLIN; MANNITOL; MYRICETIN; NEUTRAL RED; QUERCETIN; REACTIVE OXYGEN METABOLITE; TAXIFOLIN;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CELL STRAIN 3T3; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DIETARY INTAKE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0031657399     PISSN: 10979336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. AGULLO, G., GAMET, L., BESSON, C., DEMIGNE, C., and REMSEY, C. (1994). Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and Caco-2 cells. Cancer Lett. 87, 55-63.
2. AROUMA, O.I. (1994). Nutrition and health aspects of free radicals and antioxidants. Fd. Chem. Toxic. 32(7), 671-683.
3. BABICH, H., BOHRENFREUND, E., STERN, A. (1993). Comparative cytotoxicities of selected minor dietary non-nutrients with chemopreventive properties. Cancer Letters 73, 127-133.
4. BALASUBRAMANIAN, S., and GOVINDASAMY, S. (1996). Inhibitory effect of dietary flavonol quercetin on 7,12-dimethyl-benz[a]anthracene-induced hamster buccal pouch carcinogenesis. Carcinogenesis 17(4), 877-879.
5. BERGER, M.E., GOLUP, M.S., CHANG, C.T., ALKHAROUF, J.A., et al. (1992). Flavonoid potentiation of contractile responses in rat blood vessels. J. Pharmacol. Exp. Ther. 263(1), 78-83.
6. BEYELER, S., TESTA, B., and PERRISSOUD, D. (1988). Flavonoids as inhibitors of rat liver monooxygenase activities. Biochem. Pharmacol. 37, 1971-1979.
7. BIRT, D.F., WALKER, D., TIBBELS, M.B., and BRESNICK, E. (1986). Antimutagenesis and antipromotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis 7, 959-963.
8. BOHRENFREUND, E., and PUERNER, J.A. (1985). Toxicity determination in vitro by morphological alteration and nuetral red absorption. Toxicol. Lett. 24, 119-124.
9. BROWN, J.P. (1980). A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat. Res. 75, 243-277.
10. BUONARATI, M.H., TUCKER, J.D., MINKLER, J.L., WU, R.W., THOMPSON, L.H., and FELTON, J.S. (1991). Metabolic activation and cytogenic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Chinese hamster ovary cells expressing murine cytochrome P450 1A2. Mutagenesis 6(4), 253-259.
11. BURKE, M.D., THOMSON, S., WEAVER, R.J., WOLF, C.R., and MAYERS, R.T. (1994). Cytochrome P450 specificities of alkoxyresorufin-O-dealkylation in human and rat liver. Biochem. Pharm. 48, 923-936.
12. CANIVENC-LAVIER, M.-C., BRUNOLD, C., SIESS, M.H., and SUSCHETET, M. (1993). Evidence for tangeritin O-demethylation by rat and human liver microsomes. Xenobiotica. 23, 259-266.
13. CHALOUPKA, K., KRISHNAN, V., and SAFE, S. (1992). Polynuclear aromatic hydrocarbon carcinogens as antiestrogens in MCF7 human breast cancer cells: Role of AH receptor. Carcinogenesis 13(12), 2233-2239.
14. 4-induced microsomal lipid oxidation. Experimentia 47, 195-201.
15. CHRISTOU, M., SAVES, Ü., SPINK, D.C., GIERTHY, J.F., and JEFCOATE, C.R. (1994). Co-expression of human CYP1A and a human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachloro-dibenzo-p-dioxin in the human mammary carcinoma-derived MCF7 cells. Carcinogenesis 15(4), 725-732.
16. CZECZOT, H., TUDEK, B., KUSZTELAK, J., et al. (1990). Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat. Res. 240, 209-216.
17. DAS, A., WANG, J.H., and LIEN, E.J. (1994). Carcinogenicity, mutagenicity and cancer chemopreventing activities of flavonoids: A structure-system-activity relationship (SSAR) analysis. Progress Drug Res 42, 133-166.
18. DEARFIELD, K.L., JACOBSEN-KRAM, D., BROWN, N.A., and WILLIAMS, J.R. (1983). Evaluation of a human hepatoma cell line as a target cell in genetic toxicology. Mutat. Res. 108(1-3), 437-449.
19. DOEHMER, J., DOGRA, S., FRIEDBERG, T., MONIER, S., ADESNIK, M., GLATT, H., and OESCH, F. (1988). Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin B1. Proc. Natl. Acad. Sci. U.S.A. 85(16), 5769-5773.
20. DUNNICK, J.K., and HAILEY, J.R. (1992). Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam. Appl. Toxicol. 19, 423-431.
21. DUTHIE, S.J., MELVIN, W.T., and BURKE, M.D. (1994). Bromobenzene detoxification in the human liver-derived HepG2 cell line. Xenobiotica 24(3), 265-279.
22. ELANGOVAN, V., BALISUBRAMANIAN, S., SEKAR, N., and GOVINDASAMY, S. (1994a). Studies on the chemopreventive potential of some naturally-occurring bioflavonoids in 7,12-dimethyl-benz[a]anthracene-induced carcinogenesis in mouse skin. J. Clin. Biochem. Nutr. 17, 153-160.
23. ELANGOVAN, V., SEKAR, N., and GOVINDASAMY, S. (1994b). Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett 87, 107-113.
24. FERRANDIZ, M.L., NAIR, A.G., and ALCARAZ, M.J. (1990). Inhibition of sheep platelet arachidonate metabolism by flavonoids from Spanish and Indian medical herbs. Pharmazie. 45(3), 206-208.
25. GABOR, M., and RAZGA, Z. (1991). Effect of benzopyrone derivatives on simultaneously induced croton oil ear oedema and carrageenin paw oedema in rats. Acta. Physiol. Hung. 77(3-4), 197-207.
26. GAUDETTE, D.C., and HOLUB, B.J. (1990). Effect of genistein, a tyrosine kinase inhibitor on U46619-induced phosphoinositide phosphorylation in human platelets. Biochem. Biophys. Res. Commun. 170, 238-242.
27. 1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 11, 2275-2279.
28. JING, Y., and WAXMAN, S. (1995), Structural requirements for differentiation-induction and growth-inhibition of mouse erythroleukemia cells by isoflavones. Anticancer Res. 15, 1147-1152.
29. JURADO, A., ALEJANDRE, D., ALONSO, M., and PUEYO, C. (1991). Study on the mutagenic activity of 13 bioflavonoids with the Salmonella Ara test. Mutagenesis 6, 289-295.
30. KATO, R., NAKADATE, T., YAMAMOTO, S., and SUGIMURA, T. (1983). Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 4, 1301-1305.
31. KUHNAU, J. (1976). The flavonoids. A class of semiessential food components: Their role in human nutrition. World. Rev. Nutr. Diet. 24, 117-191.
32. LAUGHTON, M.J., HALLIWELL, B., EVANES, P., and HOULT, J.R.S. (1989). Antioxidant and prooxidant action of the plant phenolics quercetin, gossypol and myricetin. Biochem. Pharmacol. 38, 2859-2865.
33. MACGREGOR, J.T., and JURD, L. (1979). Mutagenicity of plant flavonoids: Structural requirements for mutagenic activity in Salmonella typhimurium. Mutat. Res. 54, 297-309.
34. MIDDLETON, E. (1984). The flavonoids. Trends Pharmacol. Sci. 5, 335-338.
35. MUSK, S.R.R., STEPHENSON, P., SMITH, T.K., STENING, P., FYFE, D., and JOHNSON, I.T. (1995). Selective toxicity of compounds naturally present in food toward the transformed phenotype of human colorectal cell line HT29. Nutrition And Cancer 24, 289-298.
36. NAKADATA, T., YAMAMOTO, S., AIZU, E., and KATO, R. (1984). Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds. Gann. 75(3), 214-222.
37. NAKAYAMA, T. (1994). Suppression of hydroperoxide-induced cytotoxicity by polyphenols. Cancer Res. 54, 1991s-1993s.
38. NIELSEN, S.E., BREINHOLT, V., JUSTESEN, U., CORNETT, C., and DRAGSTED, L.O. (1998). In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 28(4), 389-401.
39. NTP (1991) National Toxicology Program: NPT Technical Report on the Toxicology and Carcinogenesis Studies of Quercetin in F344/N Rats. NIH Publication No. 91-3140.
40. PEREIRA, M.A., GRUBBS, C.J., BARNES, L.H., et al. (1996). Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17(6), 1305-1311.
41. PETERSON, T.G., and BARNES, S. (1991). Genistein inhibition of the growth of human breast cancer cells. Independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 179, 661-667.
42. POND, A.L., ZAMORA, J.M., and WELLS, M.R. (1994). Effect of the bioflavonoid morin on HEp-2 cells. Bulletin of Environmental Contamination and Toxicology 53, 562-569.
43. RAMANATHAN, R., TAN, C.H., and DAS, N.P. (1992). Cytotoxic effect of plant polyphenols and fat-soluble vitamins on malignant human cultured cells [published erratum appears in Cancer Lett. 1992 Aug. 14;65(2):181]. Cancer Lett. 62, 217-224.
44. RATTY, A.K., and DAS, N.P. (1988). Effects of flavonoids on non-enzymatic lipid peroxidation: Structure-activity relationship. Biochem. Med. Metabol. Biol. 39, 69-79.
45. REDINBAUGH, M.G., and RURLEY, R.B. (1986). Adaption of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. Anal. Biochem. 153, 267-271.
46. SIESS, M.H., LECLERC, J., CANIVENC-LAVIER, M.C., RAT, P., and SUSCHETET, M. (1995). Heterogeneous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicol. Appl. Pharm. 130, 73-78.
47. SPINK, D.C., JOHNSON, J.A., CONNOR, S.P., ALDOUS, K.M., and GIERTHY, J.F. (1994). Stimulation of 17β-estradiol metabolism in MCF7 cells by bromochloro- and chloromethyl-substituted dibenzo-p-dioxin and dibenzofurans: Correlation with antiestrogenic activity. J. Tox. Environ. Health. 41, 451-466.
48. VERMA, A.K., JOHNSON, J.A., GOULD, M.N., and TANNER, A. (1988). Inhibition of 7,12-dimethylbenz[a]anthracene-induced and N-nitrosomethyl-urea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 48, 5754-5758.
49. VERNET, A., and SIESS, M.H. (1986). Comparison of the effect of various fiavonoids on ethoxycoumarin deethylase activity of rat intestinal and hepatic microsomes. Fd. Chem. Toxicol. 24, 857-861.
50. WEI, H., TYE, L., BRESNICK, E., and BIRT, D.F. (1990). Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion. Cancer Res. 50, 499-502.
51. YANAGIHARA, K., ITO, A., TOGE, T., and NUMOTO, M. (1993). Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Research 53, 5815-5821.
52. ZHU, B.T., and LIEHR, J.G. (1994). Quercetin increases the severity of oestradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol. 125, 149-158.
53. ZHU, B.T., EZELL, E.L., and LIEHR, J.G. (1994). Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids. J. Biol. Chem. 1, 292-299.